1. Home
  2. BELFA vs HAE Comparison

BELFA vs HAE Comparison

Compare BELFA & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bel Fuse Inc.

BELFA

Bel Fuse Inc.

BUY

Current Price

$231.50

Market Cap

2.3B

Sector

N/A

ML Signal

BUY

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$59.96

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BELFA
HAE
Founded
1949
1971
Country
United States
United States
Employees
4964
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.8B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
BELFA
HAE
Price
$231.50
$59.96
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$174.25
$84.13
AVG Volume (30 Days)
68.1K
540.5K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
0.10%
N/A
EPS Growth
N/A
44.54
EPS
N/A
2.46
Revenue
N/A
$910,373,000.00
Revenue This Year
$9.74
N/A
Revenue Next Year
$6.34
$5.23
P/E Ratio
$40.02
$24.42
Revenue Growth
N/A
N/A
52 Week Low
$62.00
$47.32
52 Week High
$255.04
$87.32

Technical Indicators

Market Signals
Indicator
BELFA
HAE
Relative Strength Index (RSI) 60.05 51.16
Support Level $114.22 $48.47
Resistance Level N/A $62.78
Average True Range (ATR) 11.29 1.93
MACD -0.34 0.05
Stochastic Oscillator 57.44 53.53

Price Performance

Historical Comparison
BELFA
HAE

About BELFA Bel Fuse Inc.

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: